Advanced Filter

Filter by Group

Filter by Market Availability

AZD9056 has been used in trials studying the basic science and treatment of Rheumatoid Arthritis.
Matched Name: … AZD-9056 …
AZD2066 has been used in trials studying the treatment and basic science of Pain, Chronic Pain, Reflux Episodes, Neuropathic Pain, and Diabetic Neuropathy, among others.
Matched Name: … AZD-2066 …
AZD1981 has been used in trials studying the treatment and basic science of Asthma, Postmenopausal, Pharmakokinetic, Asthma Patients, and Drug Interaction, among others.
Matched Name: … AZD-1981 …
AZD7295 has been investigated for the treatment of Hepatitis C.
Matched Name: … AZD-7295 …
AZD 3355 is a reflux inhibitor used for the treatment of Gastroesophageal Reflux Disease. It is developed by AstraZeneca and is currently in phase I/II trials.
Matched Name: … AZD 3355 …
Matched Description: … AZD 3355 is a reflux inhibitor used for the treatment of Gastroesophageal Reflux Disease. It is developed …
AZD1480 has been used in trials studying the treatment of Solid Malignancies, Post-Polycythaemia Vera, Primary Myelofibrosis (PMF), and Essential Thrombocythaemia Myelofibrosis.
Matched Name: … AZD-1480 …
AZD-9684 is the first member of a new anti-thrombotic class (CPU inhibitors). It is being developed by AstraZeneca.
Matched Name: … AZD-9684 …
Matched Description: … AZD-9684 is the first member of a new anti-thrombotic class (CPU inhibitors). It is being developed by …
AZD6280 has been used in trials studying the basic science of Anxiety.
Matched Name: … AZD-6280 …
AZD3409 is a farnesyl-transferase inhibitor (FAR) indicated for the treatment of solid tumors. Phase I trials were initiated January 2003, and were ongoing as of February 2004. As of February 2007 the development of AZD3409 had been discontinued.
Matched Name: … AZD3409 …
AZD2624 has been used in trials studying the basic science and treatment of Safety and Schizophrenia.
Matched Name: … AZD-2624 …
AZD1236 has been used in trials studying the basic science and treatment of Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
Matched Name: … AZD-1236 …
AZD8055 has been used in trials studying the treatment of Cancer, Lymphomas, Solid Tumors, MALIGNANT GLIOMA, and brainstem glioma, among others.
Matched Name: … AZD-8055 …
AZD7762 has been investigated for the treatment of Cancer, Solid Tumors, and Advanced Solid Malignancies.
Matched Name: … AZD-7762 …
AZD3839 has been used in trials studying the basic science of Safety, Tolerability, Alzheimer's Disease, and Blood Concentration.
Matched Name: … AZD-3839 …
AZD0947 is a K+ channel opener, which was under investigation by AstraZeneca for the treatment of overactive bladder. As of March 2003, the drug was in phase II trials; however, as of October 2004, it no longer appeared on the company’s development pipeline.
Matched Name: … AZD0947 …
Azd8418 is under investigation in clinical trial NCT01027234 (This Study Will Assess the Safety and Tolerability of AZD8418 After Single Increasing Oral Doses).
Matched Name: … AZD-8418 …
AZD4818 has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease (COPD).
Matched Name: … AZD-4818 …
AZD9164 has been used in trials studying the basic science and treatment of Chronic Obstructive Pulmonary Disease.
Matched Name: … AZD-9164 …
AZD3043 has been used in trials studying the treatment and basic science of Safety, Sedation, Tolerability, and Pharmacokinetics.
Matched Name: … AZD-3043 …
AZD-8330 is a potent, selective, orally active MEK inhibitor that blocks signal transduction pathways implicated in cancer cell proliferation and survival. AZD-8330 has shown tumor suppressive activity in multiple preclinical models of human cancer including melanoma, pancreatic, colon, lung, and breast cancers.
Matched Name: … AZD-8330 …
Matched Description: … AZD-8330 is a potent, selective, orally active MEK inhibitor that blocks signal transduction pathways ... implicated in cancer cell proliferation and survival. AZD-8330 has shown tumor suppressive activity in multiple …
AZD5363 has been investigated for the treatment of Metastatic Breast Cancer.
Matched Name: … AZD-5363 …
AZD4547 has been used in trials studying the treatment of Cancer, LYMPHOMA, Gastric Cancer, Adenocarcinoma, and Solid Neoplasm, among others.
Matched Name: … AZD-4547 …
AZD4877 has been used in trials studying the treatment of NHL, Tumors, Cancer, Lymphoma, and Neoplasms, among others.
Matched Name: … AZD-4877 …
AZD0328 has been used in trials studying the treatment and basic science of Schizophrenia and Alzheimer's Disease.
Matched Name: … AZD-0328 …
AZD0424 has been used in trials studying the treatment of Advanced Solid Tumours.
Matched Name: … AZD-0424 …
Displaying drugs 1 - 25 of 28 in total